192 related articles for article (PubMed ID: 37856141)
1. Cancers Attributable to Infections in the US in 2017: A Meta-Analysis.
Volesky-Avellaneda KD; Morais S; Walter SD; O'Brien TR; Hildesheim A; Engels EA; El-Zein M; Franco EL
JAMA Oncol; 2023 Dec; 9(12):1678-1687. PubMed ID: 37856141
[TBL] [Abstract][Full Text] [Related]
2. Cancers attributable to infections in Canada.
Volesky KD; El-Zein M; Franco EL; Brenner DR; Friedenreich CM; Ruan Y;
Prev Med; 2019 May; 122():109-117. PubMed ID: 31078164
[TBL] [Abstract][Full Text] [Related]
3. Cancer in Africa 2018: The role of infections.
Parkin DM; Hämmerl L; Ferlay J; Kantelhardt EJ
Int J Cancer; 2020 Apr; 146(8):2089-2103. PubMed ID: 31254479
[TBL] [Abstract][Full Text] [Related]
4. Estimates of the incidence of infection-related cancers in Italy and Italian regions in 2018.
DE Flora S; LA Maestra S; Crocetti E; Mangone L; Bianconi F; Stracci F; Buzzoni C
J Prev Med Hyg; 2019 Dec; 60(4):E311-E326. PubMed ID: 31967088
[TBL] [Abstract][Full Text] [Related]
5. Cancers attributable to infectious agents in Italy.
Collatuzzo G; La Vecchia C; Parazzini F; Alicandro G; Turati F; Di Maso M; Malvezzi M; Pelucchi C; Negri E; Boffetta P
Eur J Cancer; 2023 Apr; 183():69-78. PubMed ID: 36801622
[TBL] [Abstract][Full Text] [Related]
6. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment.
Chen W; Xia C; Zheng R; Zhou M; Lin C; Zeng H; Zhang S; Wang L; Yang Z; Sun K; Li H; Brown MD; Islami F; Bray F; Jemal A; He J
Lancet Glob Health; 2019 Feb; 7(2):e257-e269. PubMed ID: 30683243
[TBL] [Abstract][Full Text] [Related]
7. The global health burden of infection-associated cancers in the year 2002.
Parkin DM
Int J Cancer; 2006 Jun; 118(12):3030-44. PubMed ID: 16404738
[TBL] [Abstract][Full Text] [Related]
8. Racial/Ethnic Differences in Cancers Attributable to Preventable Infectious Agents in Texas, 2015.
Gudenkauf FJ; Thrift AP
Public Health Rep; 2020; 135(6):805-812. PubMed ID: 33080142
[TBL] [Abstract][Full Text] [Related]
9. Infection and cancer: global distribution and burden of diseases.
Oh JK; Weiderpass E
Ann Glob Health; 2014; 80(5):384-92. PubMed ID: 25512154
[TBL] [Abstract][Full Text] [Related]
10. Infection, immunity, and cancer.
Persing DH; Prendergast FG
Arch Pathol Lab Med; 1999 Nov; 123(11):1015-22. PubMed ID: 10539899
[TBL] [Abstract][Full Text] [Related]
11. Human Oncogenic Viruses: Characteristics and Prevention Strategies-Lessons Learned from Human Papillomaviruses.
Galati L; Chiantore MV; Marinaro M; Di Bonito P
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543781
[TBL] [Abstract][Full Text] [Related]
12. Cancers attributable to infections among adults with HIV in the United States.
de Martel C; Shiels MS; Franceschi S; Simard EP; Vignat J; Hall HI; Engels EA; Plummer M
AIDS; 2015 Oct; 29(16):2173-81. PubMed ID: 26182198
[TBL] [Abstract][Full Text] [Related]
13. The Fraction of Cancer Attributable to Ways of Life, Infections, Occupation, and Environmental Agents in Brazil in 2020.
Azevedo E Silva G; de Moura L; Curado MP; Gomes Fda S; Otero U; Rezende LF; Daumas RP; Guimarães RM; Meira KC; Leite Ida C; Valente JG; Moreira RI; Koifman R; Malta DC; Mello MS; Guedes TW; Boffetta P
PLoS One; 2016; 11(2):e0148761. PubMed ID: 26863517
[TBL] [Abstract][Full Text] [Related]
14. Association between
de Souza CRT; Almeida MCA; Khayat AS; da Silva EL; Soares PC; Chaves LC; Burbano RMR
World J Gastroenterol; 2018 Nov; 24(43):4928-4938. PubMed ID: 30487702
[TBL] [Abstract][Full Text] [Related]
15. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention: Hepatitis viruses, human T-cell leukemia viruses, herpesviruses, and Epstein-Barr virus.
Mui UN; Haley CT; Vangipuram R; Tyring SK
J Am Acad Dermatol; 2019 Jul; 81(1):23-41. PubMed ID: 30502415
[TBL] [Abstract][Full Text] [Related]
16. Estimates of the future burden of cancer attributable to infections in Canada.
Volesky KD; El-Zein M; Franco EL; Brenner DR; Friedenreich CM; Ruan Y;
Prev Med; 2019 May; 122():118-127. PubMed ID: 31078165
[TBL] [Abstract][Full Text] [Related]
17. The cancer burden attributable to biologic agents.
Schottenfeld D; Beebe-Dimmer J
Ann Epidemiol; 2015 Mar; 25(3):183-7. PubMed ID: 25523895
[TBL] [Abstract][Full Text] [Related]
18. Associations Between Gastric Cancer Risk and Virus Infection Other Than Epstein-Barr Virus: A Systematic Review and Meta-analysis Based on Epidemiological Studies.
Wang H; Chen XL; Liu K; Bai D; Zhang WH; Chen XZ; Hu JK;
Clin Transl Gastroenterol; 2020 Jul; 11(7):e00201. PubMed ID: 32764207
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.
Kahn JA; Rudy BJ; Xu J; Kapogiannis B; Secord E; Gillison M
J Med Virol; 2016 Nov; 88(11):1944-52. PubMed ID: 27096166
[TBL] [Abstract][Full Text] [Related]
20. The role of infections in the causation of cancer in Kenya.
Tuei VC; Maiyoh GK; Ndombera FT
Cancer Causes Control; 2022 Dec; 33(12):1391-1400. PubMed ID: 36087193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
